SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-057685
Filing Date
2022-09-21
Accepted
2022-09-21 16:05:23
Documents
1
Period of Report
2022-11-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea166031-def14a_tffpharma.htm DEF 14A 293678
  Complete submission text file 0001213900-22-057685.txt   294671
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39102 | Film No.: 221256475
SIC: 2834 Pharmaceutical Preparations